000 01216 a2200337 4500
005 20250513192024.0
264 0 _c19991004
008 199910s 0 0 eng d
022 _a1527-9995
024 7 _a10.1016/s0090-4295(99)00259-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGleason, D M
245 0 0 _aEvaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group.
_h[electronic resource]
260 _bUrology
_cSep 1999
300 _a420-3 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aCholinergic Antagonists
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMandelic Acids
_xadministration & dosage
650 0 4 _aUrinary Incontinence
_xdrug therapy
700 1 _aSusset, J
700 1 _aWhite, C
700 1 _aMunoz, D R
700 1 _aSand, P K
773 0 _tUrology
_gvol. 54
_gno. 3
_gp. 420-3
856 4 0 _uhttps://doi.org/10.1016/s0090-4295(99)00259-9
_zAvailable from publisher's website
999 _c10432786
_d10432786